APP and early-onset autosomal dominant Alzheimer disease: The molecular pathology of Alzheimer's disease (AD) is characterized by increased accumulation of 39 to 43 residue long beta-amyloid peptides (Aβ) in plaques in the brains of Alzheimer's disease (AD) patients.